326 related articles for article (PubMed ID: 8776731)
1. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens.
Galien R; Evans HF; Garcia T
Mol Endocrinol; 1996 Jun; 10(6):713-22. PubMed ID: 8776731
[TBL] [Abstract][Full Text] [Related]
2. The kappa B enhancer of the human interleukin-6 promoter is necessary and sufficient to confer an IL-1 beta and TNF-alpha response in transfected human cell lines: requirement for members of the C/EBP family for activity.
Merola M; Blanchard B; Tovey MG
J Interferon Cytokine Res; 1996 Oct; 16(10):783-98. PubMed ID: 8910763
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site.
Galien R; Garcia T
Nucleic Acids Res; 1997 Jun; 25(12):2424-9. PubMed ID: 9171095
[TBL] [Abstract][Full Text] [Related]
4. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor.
Kurebayashi S; Miyashita Y; Hirose T; Kasayama S; Akira S; Kishimoto T
J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):11-7. PubMed ID: 9182853
[TBL] [Abstract][Full Text] [Related]
5. [Synergism between transcription factors NF-IL6 and NF-kappa B in IL-6 gene regulation].
Fujikawa K
Hokkaido Igaku Zasshi; 1992 Jul; 67(4):563-74. PubMed ID: 1427600
[TBL] [Abstract][Full Text] [Related]
6. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta.
Stein B; Yang MX
Mol Cell Biol; 1995 Sep; 15(9):4971-9. PubMed ID: 7651415
[TBL] [Abstract][Full Text] [Related]
7. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.
Quaedackers ME; Van Den Brink CE; Wissink S; Schreurs RH; Gustafsson JA; Van Der Saag PT; Van Der Burg BB
Endocrinology; 2001 Mar; 142(3):1156-66. PubMed ID: 11181531
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor kappa B (NF-kappa B), nuclear factor interleukin-6 (NFIL-6 or C/EBP beta) and nuclear factor interleukin-6 beta (NFIL6-beta or C/EBP delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6-expressing human breast carcinoma cell line.
Faggioli L; Costanzo C; Merola M; Bianchini E; Furia A; Carsana A; Palmieri M
Eur J Biochem; 1996 Aug; 239(3):624-31. PubMed ID: 8774705
[TBL] [Abstract][Full Text] [Related]
9. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide-mediated induction of the bovine interleukin-6 gene in monocytes requires both NF-kappa B and C/EBP binding sites.
Ray A; Ray BK
DNA Cell Biol; 1995 Sep; 14(9):795-802. PubMed ID: 7669256
[TBL] [Abstract][Full Text] [Related]
11. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B.
Stein B; Baldwin AS
Mol Cell Biol; 1993 Nov; 13(11):7191-8. PubMed ID: 8413306
[TBL] [Abstract][Full Text] [Related]
12. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6.
Yan SF; Tritto I; Pinsky D; Liao H; Huang J; Fuller G; Brett J; May L; Stern D
J Biol Chem; 1995 May; 270(19):11463-71. PubMed ID: 7744784
[TBL] [Abstract][Full Text] [Related]
13. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor.
Ray P; Ghosh SK; Zhang DH; Ray A
FEBS Lett; 1997 Jun; 409(1):79-85. PubMed ID: 9199508
[TBL] [Abstract][Full Text] [Related]
14. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6.
Kunsch C; Lang RK; Rosen CA; Shannon MF
J Immunol; 1994 Jul; 153(1):153-64. PubMed ID: 8207232
[TBL] [Abstract][Full Text] [Related]
15. Cooperative effects of C/EBP-like and NF kappa B-like binding sites on rat serum amyloid A1 gene expression in liver cells.
Li X; Liao WS
Nucleic Acids Res; 1992 Sep; 20(18):4765-72. PubMed ID: 1408789
[TBL] [Abstract][Full Text] [Related]
16. Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6 and NF-kappa B) which are involved in IL-6 regulation.
Dokter WH; Koopmans SB; Vellenga E
Leukemia; 1996 Aug; 10(8):1308-16. PubMed ID: 8709636
[TBL] [Abstract][Full Text] [Related]
17. Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts.
Bodine PV; Harris HA; Komm BS
Endocrinology; 1999 Jun; 140(6):2439-51. PubMed ID: 10342828
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of a human osteosarcoma cell line stably transfected with the human estrogen receptor gene.
Huo B; Dossing DA; Dimuzio MT
J Bone Miner Res; 1995 May; 10(5):769-81. PubMed ID: 7639112
[TBL] [Abstract][Full Text] [Related]
19. Expression of rat serum amyloid A1 gene involves both C/EBP-like and NF kappa B-like transcription factors.
Li XX; Liao WS
J Biol Chem; 1991 Aug; 266(23):15192-201. PubMed ID: 1869549
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions.
Wang W; Dong L; Saville B; Safe S
Mol Endocrinol; 1999 Aug; 13(8):1373-87. PubMed ID: 10446910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
